Free for academic non-profit institutions. Other users need a Commercial license
PDE3B (Phosphodiesterase 3B) is a Protein Coding gene. Diseases associated with PDE3B include Pseudohypoparathyroidism, Type Ii and Pelizaeus-Merzbacher Disease. Among its related pathways are Sweet Taste Signaling and Signal transduction_PKA signaling. Gene Ontology (GO) annotations related to this gene include 3',5'-cyclic-nucleotide phosphodiesterase activity and cGMP-inhibited cyclic-nucleotide phosphodiesterase activity. An important paralog of this gene is PDE3A.
Phosphodiesterases (PDEs) are a family of phosphohydrolyases that catalyze the hydrolysis of 3' cyclic phosphate bonds in adenosine and/or guanine 3',5' cyclic monophosphate (cAMP and/or cGMP). PDEs regulate the second messengers by controlling their degradation.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity | EXP,TAS | 17884339 |
GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity | IBA | 21873635 |
GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity | TAS | 8884271 |
GO:0005515 | protein binding | IPI | 17255105 |
GO:0008081 | phosphoric diester hydrolase activity | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005783 | endoplasmic reticulum | ISS | -- |
GO:0005794 | Golgi apparatus | ISS | -- |
GO:0005829 | cytosol | TAS | -- |
GO:0016020 | membrane | IDA | 18586889 |
GO:0016021 | integral component of membrane | IEA | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | RET signaling | ||
2 | Activation of cAMP-Dependent PKA |
Activation of cAMP-Dependent PKA
.77
cAMP Pathway
.77
|
Activation of PKA through GPCR
.71
PKA Signaling
.56
|
3 | Sweet Taste Signaling |
Sweet Taste Signaling
.72
Cellular Effects of Sildenafil
.46
|
Bitter Taste Signaling
.44
Sperm Motility
.37
|
4 | Regulation of lipid metabolism Insulin signaling-generic cascades |
Regulation of lipid metabolism Insulin signaling-generic cascades
.59
|
|
5 | Signaling by GPCR |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0001525 | angiogenesis | IEA | -- |
GO:0007162 | negative regulation of cell adhesion | IMP | 17884339 |
GO:0007165 | signal transduction | IEA | -- |
GO:0007186 | G protein-coupled receptor signaling pathway | TAS | -- |
GO:0016525 | negative regulation of angiogenesis | IMP | 21393242 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Milrinone | Approved | Pharma | Inhibitor, Inhibition, inhibitor | PDE-3 inhibitor | 49 | |
Cilostazol | Approved, Investigational | Pharma | inhibitor | PDE3 inhibitor | 126 | |
Amrinone | Approved | Pharma | Target, inhibitor | 0 | ||
Caffeine | Approved | Pharma | Antagonist, Activator, Target, Target, inhibitor | 603 | ||
Water | Approved | Pharma | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
IBMX |
|
Antagonist | 28822-58-4 |
|
||
Eggmanone |
|
505068-32-6 |
|
|
||
Etazolate hydrochloride |
|
35838-58-5 |
|
|
||
MY-5445 |
|
78351-75-4 |
|
|
||
Ro 20-1724 |
|
29925-17-5 |
|
|
Compound | Action | Cas Number |
---|---|---|
Eggmanone | Potent and selective PDE4 inhibitor; suppresses hedgehog signaling | 505068-32-6 |
Etazolate hydrochloride | PDE4 inhibitor | 35838-58-5 |
IBMX | PDE inhibitor (non-selective) | 28822-58-4 |
MY-5445 | PDE5 inhibitor | 78351-75-4 |
Ro 20-1724 | PDE4 inhibitor | 29925-17-5 |
Compound | Action | Cas Number |
---|---|---|
Cilostazol | PDE3 inhibitor | 73963-72-1 |
Milrinone | PDE-3 inhibitor | 78415-72-2 |
Pimobendan | Selective PDE3 inhibitor.Ca2+ channel sensitizer | 74150-27-9 |
This gene was present in the common ancestor of chordates.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | PDE3B 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | PDE3B 30 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | PDE3B 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Pde3b 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Pde3b 30 |
|
||
Dog (Canis familiaris) |
Mammalia | PDE3B 30 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | PDE3B 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | PDE3B 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | PDE3B 31 |
|
OneToOne | |
Zebrafish (Danio rerio) |
Actinopterygii | pde3b 30 |
|
||
PDE3B 31 |
|
OneToOne | |||
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
OneToMany | |
Sea Vase (Ciona intestinalis) |
Ascidiacea | Cin.13290 30 |
|
SNP ID | Clinical significance and condition | Chr 11 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
709843 | Benign: not provided | 14,859,183(+) | T/C | SYNONYMOUS_VARIANT | |
709844 | Benign: not provided | 14,859,255(+) | T/C | INTRON_VARIANT | |
709845 | Benign: not provided | 14,861,210(+) | T/C | SYNONYMOUS_VARIANT | |
724497 | Benign: not provided | 14,644,840(+) | T/G | SYNONYMOUS_VARIANT | |
736617 | Benign: not provided | 14,869,468(+) | A/G | SYNONYMOUS_VARIANT |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
esv1063774 | CNV | insertion | 17803354 |
esv3578250 | CNV | gain | 25503493 |
esv3625426 | CNV | loss | 21293372 |
esv3625427 | CNV | loss | 21293372 |
esv3625428 | CNV | loss | 21293372 |
esv3625429 | CNV | gain | 21293372 |
esv3891931 | CNV | loss | 25118596 |
nsv1042405 | CNV | loss | 25217958 |
nsv1048243 | CNV | gain | 25217958 |
nsv1118490 | CNV | duplication | 24896259 |
nsv517985 | CNV | loss | 19592680 |
nsv553561 | CNV | gain | 21841781 |
nsv832071 | CNV | loss | 17160897 |
nsv982986 | CNV | duplication | 23825009 |
Disorder | Aliases | PubMed IDs |
---|---|---|
pseudohypoparathyroidism, type ii |
|
|
pelizaeus-merzbacher disease |
|
|
brachydactyly |
|
|
diabetes mellitus, noninsulin-dependent |
|
|
leukemia, chronic lymphocytic |
|